Turnover
≈ €140,000 estimated
The micro format states no turnover.
MEDIKAS
Lifetime
2 annual accounts with figures on one time axispeak €62,250 (2025)
€62,250▲ 319%
peak €33,784 (2025)
€33,784▲ 965%
peak €40,456 (2025)
€40,456▲ 506%
€148,687▼ 8.9%
Board1 name since 2024
1 director
Documentsfilings and deeds
29-10-202690 days late
2025micro format
Gross margin from €14,848 to €62,250Result from €3,172 to €33,784Equity from €6,672 to €40,456Cash from €14,265 to €46,814
Key points
from the 2025 annual accountsDebts
€148,687 79% of the balance sheet
Suppliers 1%Taxes and wages 9%Other 91%
Starting capital
€3,500
2025 accounts filed 90 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 7,983 companies had the same profile as MEDIKAS has now. Each dot stands for 20 companies, two years later.
94.2%
were still trading
1.9%
stopped another way
3.6%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,983 companies, not a prediction for MEDIKAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Incorporation
Founding capital of €3,500 · Appointment: (director) · Registered office clause: avenue Fond Jean Rosy 10, 1330 Rixensart · published on 17-06-2024 · Gazette deed
First establishment
Avenue Fond Jean Rosy 10, Rixensart
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MEDIKAS Rixensart | €189,143 | €62,250 | 21.4% | - |
| MUGANGA Tubize | €178,403 | €56,013 | 10.8% | - |
| Dr. Souffriau Nele Haaltert | €184,770 | €63,833 | 22.9% | - |
| Aline Verschueren Antwerp | €172,509 | €58,227 | 45.2% | 0 |
| Dr. Govarts Anouk Scherpenheuvel-Zichem | €184,986 | €67,243 | 84.2% | - |
| Docteur RIKIR Anne-France Herve | €210,328 | €67,385 | 9.1% | - |
| Docteur Adrian Mattens Waterloo | €149,949 | €75,924 | 71.6% | - |
These companies have the same main activity as MEDIKAS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €150,000 and €210,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 13-06-2024Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.361.250.6101330 Rixensart, since 13-06-2024
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on MEDIKAS
MEDIKAS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,456 and a net result of €33,784.
Its solvency ranks better than 21% of 21,330 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDIKAS
- What is the company number of MEDIKAS?
- The company number of MEDIKAS is 1010.343.189. The VAT number is the same number with BE in front: BE 1010.343.189.
- Where is MEDIKAS based?
- The registered office is at Avenue Fond Jean Rosy 10, 1330 Rixensart.Company details
- What does MEDIKAS do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of MEDIKAS?
- MEDIKAS is a private limited company (BV).
- When was MEDIKAS founded?
- MEDIKAS was founded on 13-06-2024.
- Is MEDIKAS still active?
- Yes, MEDIKAS is an active enterprise in the KBO register.
- What is the turnover of MEDIKAS?
- The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €62,250 and 34 comparable companies (NACE 862). It probably lies between €110,000 and €170,000.Financials
- Is MEDIKAS profitable?
- In financial year 2025, MEDIKAS made a profit of €33,784.
- Where can I find the annual accounts of MEDIKAS?
- MEDIKAS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDIKAS due?
- MEDIKAS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.